Increasing genetic diversity of hepatitis C virus in haemophiliacs with human immunodeficiency virus coinfection

Journal of General Virology

Volumn 88, Issue 9, 2007, Pages 2513-2519

  Tanaka, Yasuhito ^a   Hanada, Kousuke ^b   Hanabusa, Hideji ^c   Kurbanov, Fuat ^a   Gojobori, Takashi ^b   Mizokami, Masashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF GENETICS   (Japan)

^c Ogikubo Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GLYCOPROTEIN E1; GLYCOPROTEIN E2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; GENOTYPE; HEMOPHILIA; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INTERMETHOD COMPARISON; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SUPERINFECTION; VIRUS ENVELOPE; VIRUS MORPHOLOGY;

ADULT; CLONING, MOLECULAR; GENOME, VIRAL; HEMOPHILIA A; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, VIRAL; VARIATION (GENETICS);

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 34548235988     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82974-0     Document Type: Article

References (35)

1. Babik J. M. & Holodniy, M. (2003). Impact of highly active anti-retroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients. J Virol 77, 1940-1950.
2. Benhamou, Y., Bochet M., Di Martino, V., Charlotte, F., Azria, F., Coutellier, A., Vidaud, M., Bricaire, F., Opolon, P. & other authors (1999). Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30, 1054-1058.
3. Bice, I., McGovern, B., Dhar, R., Stone, D., McGowan, K., Scheib, R. & Snydman, D. R. (2001). Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 32, 492-497.
4. Blackard, J. T., Yang, Y., Bordoni, P., Sherman, K. E., Chung, R. T. & AIDS Clinical Trials Group 383 Study Team (2004). Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy. J Infect Dis 189, 1472-1481.
5. Braitstein, P., Palepu, A., Dieterich, D., Benhamou, Y. & Montaner, J. S. (2004). Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis C. AIDS 18, 2221-2234.
6. Devereux, H. L., Brown, D., Dusheiko, G. M., Emery, V. C. & Lee, C. A. (1997). Long-term evolution of the 5′UTR and a region of NS4 containing a CTL epitope of hepatitis C virus in two haemophilic patients. J Gen Virol 78, 583-590.
7. Eyster, M. E., Fried, M. W., Di Bisceglie, A. M. & Goedert, J. J. (1994). Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood 84, 1020-1023.
8. Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J. C., Strazzera, A., Chien, D. Y., Munoz, S. J. & other authors (2000). The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288, 339-344.
9. Farci, P., Strazzera, R., Alter, H. J., Fard, S., Degioannis, D., Coiana, A., Peddis, G., Usai, F., Serra, G. & other authors (2002). Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc Natl Acad Sci U S A 99, 3081-3086.
10. Goedert J. J., Eyster, M. E., Lederman, M. M., Mandalaki, T., De Moerloose, P., White, G. C., II, Angiolillo, A. L., Luban, N. L., Sherman, K. E. & other authors (2002). End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood 100, 1584-1589.
11. Graham, C. S., Baden, L. R., Yu, E., Mrus, J. M., Carnie, J., Heeren, T. & Koziel, M. J. (2001). Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 33, 562-569.
12. Hanada, K., Gojobori, T. & Li, W. H. (2006). Radical amino acid change versus positive selection in the evolution of viral envelope proteins. Gene 385, 83-88.
13. Hanada, K., Tanaka, Y., Mizokami, M., Gojobori, T. & Alter, H. J. (2006). A reduction in selective immune pressure during the course of chronic hepatitis C correlates with diminished biochemical evidence of hepatic inflammation. Virology 361, 27-33.
14. Kato, N., Sekiya, H., Ootsuyama, Y., Nakazawa, T., Hijikata, M., Ohkoshi, S. & Shimotohno, K. (1993). Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 67, 3923-3930.
15. Kumar, S., Tamura, K., Jakobsen, I. B. & Nei, M. (2001). MEGA2: Molecular Evolutionary Genetics Analysis software. Bioinformatics 17, 1244-1245.
16. Lai, C. L., Ratziu, V., Yuen, M. F. & Poynard, T. (2003). Viral hepatitis B. Lancet 362, 2089-2094.
17. Lyra, A. C., Fan, X., Lang, D. M., Yusim, K., Ramrakhiani, S., Brunt E. M., Korber, B., Perelson, A. S. & Di Bisceglie, A. M. (2002). Evolution of hepatitis C viral quasispecies after liver transplantation. Gastroenterology 123, 1485-1493.
18. Mao, O., Ray, S. C., Laeyendecker, O., Ticehurst, J. R., Strathdee, S. A., Vlahov, D. & Thomas, D. L. (2001). Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies. J Virol 75, 3259-3267.
19. Martell, M., Esteban, J. I., Quer, J., Genesca, J., Weiner, A., Esteban, R., Guardia, J. & Gomez, J. (1992). Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 66, 3225-3229.
20. Neumann, A. U., Lam, N. P., Dahari, H., Gretch, D. R., Wiley, T. E., Layden, T. J. & Perelson, A. S. (1998). Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282, 103-107.
21. Ohno, T., Mizokami, M., Wu, R. R., Saleh, M. G., Ohba, K, Orito, E., Mukaide, M., Williams, R. & Lau, J. Y. (1997). New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes la, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 35, 201-207.
22. Pawlotsky, J. M., Germanidis, G., Frainais, P. O., Bouvier, M., Soulier, A., Pellerin, M. & Dhumeaux, D. (1999). Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy. J Virol 73, 6490-6499.
23. Poynard, T., Yuen, M. F., Ratziu, V. & Lai, C. L. (2003). Viral hepatitis C. Lancet 362, 2095-2100.
24. Puoti, M., Bonacini, M., Spinetti, A., Putzolu, V., Govindarajan, S., Zaltron, S., Favret, M., Callea, F., Gargiulo, F. & other authors (2001). Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis 183, 134-137.
25. Pybus, O. G. & Rambaut, A. (2002). GENIE: estimating demographic history from molecular phylogenies. Bioinformatics 18, 1404-1405.
26. Pybus, O. G., Charleston, M. A., Gupta, S., Rambaut, A., Holmes, E. C. & Harvey, P. H. (2001). The epidemic behavior of the hepatitis C virus. Science 292, 2323-2325.
27. Oin, H., Shire, N. J., Keenan, E. D., Rouster, S. D., Eyster, M. E., Goedert, J. J., Koziel, M. J. & Sherman, K. E. (2005). HCV quasi-species evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood 105, 533-541.
28. Rambaut, A. (2000). Estimating the rate of molecular evolution: incorporating non-contemporaneous sequences into maximum likelihood phylogenies. Bioinformatics 16, 395-399.
29. Ray, S. C., Mao, O., Lanford, R. E., Bassett S., Laeyendecker, O., Wang, Y. M. & Thomas, D. L. (2000). Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees. J Virol 74, 3058-3066.
30. Roque-Afonso, A. M., Robain, M., Simoneau, D., Rodriguez-Mathieu, P., Gigou, M., Meyer, L. & Dussaix, E. (2002). Influence of CD4 cell counts on the genetic heterogeneity of hepatitis C virus in patients coinfected with human immunodeficiency virus. J Infect Dis 185, 728-733.
31. Sheridan, I., Pybus, O. G., Holmes, E. C. & Klenerman, P. (2004). High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression. J Virol 78, 3447-3454.
32. Suzuki, Y. & Gojobori, T. (2001). Positively selected amino acid sites in the entire coding region of hepatitis C virus subtype 1b. Gene 276, 83-87.
33. Tanaka, Y., Hanada, K., Mizokami, M., Yeo, A. E., Shih, J. W., Gojobori, T. & Alter, H. J. (2002). A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A 99, 15584-15589.
34. Toyoda, H., Fukuda, Y., Koyama, Y., Takamatsu, J., Saito, H. & Hayakawa, T. (1997). Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepatol 26, 975-982.
35. Yang, Z., Kumar, S. & Nei, M. (1995). A new method of inference of ancestral nucleotide and amino acid sequences. Genetics 141, 1641-1650.